NO20015147D0 - Polymorf av 5-(4-(2-(N-metyl-N-(2- pyridyl)amino)etoksy)benzyl)tiazolidin-2,4-dion, maleinsyresalt - Google Patents

Polymorf av 5-(4-(2-(N-metyl-N-(2- pyridyl)amino)etoksy)benzyl)tiazolidin-2,4-dion, maleinsyresalt

Info

Publication number
NO20015147D0
NO20015147D0 NO20015147A NO20015147A NO20015147D0 NO 20015147 D0 NO20015147 D0 NO 20015147D0 NO 20015147 A NO20015147 A NO 20015147A NO 20015147 A NO20015147 A NO 20015147A NO 20015147 D0 NO20015147 D0 NO 20015147D0
Authority
NO
Norway
Prior art keywords
thiazolidine
polymorph
dione
pyridyl
ethoxy
Prior art date
Application number
NO20015147A
Other languages
English (en)
Other versions
NO20015147L (no
NO320574B1 (no
Inventor
Paul David James Blackler
Robert Gordon Giles
Christine Marie Browne
Timothy G Coakley
Gillian Morrissey
Original Assignee
Smithkline Beecham Cork Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20015147(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9909473.2A external-priority patent/GB9909473D0/en
Priority claimed from GBGB9912196.4A external-priority patent/GB9912196D0/en
Application filed by Smithkline Beecham Cork Ltd filed Critical Smithkline Beecham Cork Ltd
Publication of NO20015147D0 publication Critical patent/NO20015147D0/no
Publication of NO20015147L publication Critical patent/NO20015147L/no
Publication of NO320574B1 publication Critical patent/NO320574B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
NO20015147A 1999-04-23 2001-10-22 Polymorf av 5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)tiazolidin-2,4-dion-maleinsyresalt, anvendelse og fremgangsmate for fremstilling derav samt farmasoytisk preparat. NO320574B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909473.2A GB9909473D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912196.4A GB9912196D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical
PCT/GB2000/001520 WO2000064896A1 (en) 1999-04-23 2000-04-19 Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt

Publications (3)

Publication Number Publication Date
NO20015147D0 true NO20015147D0 (no) 2001-10-22
NO20015147L NO20015147L (no) 2001-12-17
NO320574B1 NO320574B1 (no) 2005-12-27

Family

ID=26315461

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015147A NO320574B1 (no) 1999-04-23 2001-10-22 Polymorf av 5-(4-(2-(N-metyl-N-(2-pyridyl)amino)etoksy)benzyl)tiazolidin-2,4-dion-maleinsyresalt, anvendelse og fremgangsmate for fremstilling derav samt farmasoytisk preparat.

Country Status (40)

Country Link
US (2) US6806280B1 (no)
EP (2) EP1304330A3 (no)
JP (1) JP2002543077A (no)
KR (1) KR100744360B1 (no)
CN (1) CN1167702C (no)
AP (1) AP1598A (no)
AR (2) AR023561A1 (no)
AT (1) ATE246191T1 (no)
AU (1) AU765005B2 (no)
BG (1) BG65485B1 (no)
BR (1) BR0009932A (no)
CA (1) CA2370280A1 (no)
CO (1) CO5170421A1 (no)
CZ (1) CZ20013800A3 (no)
DE (1) DE60004196T2 (no)
DK (1) DK1173435T3 (no)
DZ (1) DZ3156A1 (no)
EA (1) EA004541B1 (no)
ES (1) ES2203453T3 (no)
HK (1) HK1045153B (no)
HR (1) HRP20010772B1 (no)
HU (1) HUP0200931A3 (no)
IL (1) IL146111A0 (no)
MA (1) MA25356A1 (no)
MX (1) MXPA01010821A (no)
MY (1) MY131973A (no)
NO (1) NO320574B1 (no)
NZ (1) NZ515168A (no)
OA (1) OA11872A (no)
PE (1) PE20010044A1 (no)
PL (1) PL351684A1 (no)
PT (1) PT1173435E (no)
SK (1) SK286427B6 (no)
TR (1) TR200103062T2 (no)
TW (1) TWI283677B (no)
UA (1) UA67844C2 (no)
UY (1) UY26121A1 (no)
WO (1) WO2000064896A1 (no)
YU (1) YU75301A (no)
ZA (1) ZA200108719B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
WO2000064892A2 (en) 1999-04-23 2000-11-02 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
BR0114196A (pt) * 2000-09-26 2003-07-22 Reddy S Res Foundation Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.
KR100673140B1 (ko) * 2002-04-19 2007-01-22 파에스 파마, 에스.에이. 4-[2-[4-[1-(2-에톡시에틸)-1Ｈ-벤즈이미다졸-2-일] -1-피페리디닐]에틸]- α,α-디메틸- 벤젠아세틱 애시드의 동질이상체
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (en) * 2004-01-28 2006-10-11 Usv Limited A process for the preparation of 5- 4- 2- n-methyl -n-(2-pyridyl) amino ethoxy phenyl methyl thiaz olidine-2, 4-dione maleate
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US20090076093A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched rosiglitazone
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Ｊａｋ激酶家族之小分子抑制劑

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
US6462337B1 (en) * 2000-04-20 2002-10-08 Agilent Technologies, Inc. Mass spectrometer electrospray ionization
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
UY24886A1 (es) * 1997-02-18 2001-08-27 Smithkline Beecham Plc Tiazolidindiona
US6632947B2 (en) * 1997-02-18 2003-10-14 Smithkline Beecham Plc Process for the preparation of substituted thiazolidinedione
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
US7091359B2 (en) * 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US6613785B2 (en) * 1998-07-21 2003-09-02 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
EP1175418A2 (en) 1999-04-23 2002-01-30 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
WO2000064892A2 (en) 1999-04-23 2000-11-02 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CN1277965A (zh) 2000-06-14 2000-12-27 中国医药研究开发中心 盐酸罗格列酮及其应用
BR0114196A (pt) 2000-09-26 2003-07-22 Reddy S Res Foundation Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.

Also Published As

Publication number Publication date
YU75301A (sh) 2004-07-15
KR100744360B1 (ko) 2007-07-30
MA25356A1 (fr) 2001-12-31
CZ20013800A3 (cs) 2002-04-17
BG106121A (en) 2002-05-31
NO20015147L (no) 2001-12-17
EP1173435B1 (en) 2003-07-30
OA11872A (en) 2006-03-27
HK1045153A1 (en) 2002-11-15
HRP20010772A2 (en) 2002-10-31
US20050080114A1 (en) 2005-04-14
IL146111A0 (en) 2002-07-25
UY26121A1 (es) 2000-12-29
CN1167702C (zh) 2004-09-22
CO5170421A1 (es) 2002-06-27
SK286427B6 (sk) 2008-09-05
EP1173435A1 (en) 2002-01-23
CN1356999A (zh) 2002-07-03
ES2203453T3 (es) 2004-04-16
AU765005B2 (en) 2003-09-04
MXPA01010821A (es) 2003-09-04
WO2000064896A9 (en) 2001-10-25
US6806280B1 (en) 2004-10-19
TR200103062T2 (tr) 2002-05-21
UA67844C2 (uk) 2004-07-15
HK1045153B (zh) 2004-07-09
WO2000064896A1 (en) 2000-11-02
MY131973A (en) 2007-09-28
PL351684A1 (en) 2003-06-02
AU4130800A (en) 2000-11-10
NZ515168A (en) 2004-02-27
BR0009932A (pt) 2002-04-09
PE20010044A1 (es) 2001-03-10
HRP20010772B1 (en) 2007-05-31
AP1598A (en) 2006-04-26
EA200101121A1 (ru) 2002-04-25
TWI283677B (en) 2007-07-11
AR023565A1 (es) 2002-09-04
HUP0200931A3 (en) 2004-03-29
DE60004196D1 (de) 2003-09-04
DK1173435T3 (da) 2003-11-24
KR20010110797A (ko) 2001-12-13
AP2001002330A0 (en) 2000-12-31
JP2002543077A (ja) 2002-12-17
EP1304330A2 (en) 2003-04-23
AR023561A1 (es) 2002-09-04
HUP0200931A2 (en) 2002-08-28
DE60004196T2 (de) 2004-04-15
CA2370280A1 (en) 2000-11-02
SK14922001A3 (sk) 2002-02-05
PT1173435E (pt) 2003-12-31
EP1304330A3 (en) 2003-11-19
EA004541B1 (ru) 2004-06-24
ZA200108719B (en) 2002-06-21
ATE246191T1 (de) 2003-08-15
NO320574B1 (no) 2005-12-27
BG65485B1 (bg) 2008-09-30
DZ3156A1 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
NO20015147L (no) Polymorf av 5-(4-(2-(N-metyl-N-(2- pyridyl)amino)etoksy)benzyl)tiazolidin-2,4-dion, maleinsyresalt
NO20024307D0 (no) Hydrokloridsalter av 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
AU9123201A (en) Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparation
IL136424A0 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
IL136381A0 (en) Hydrate of 5-[4-[2-(n- methyl-n-(2-(pyridil)amino) ethoxy]benzyl] thiazolidine-2,4- dione maleic acid salt
NO20031020D0 (no) Hydrokloridsalt av 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
IL188116A0 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
SI1173435T1 (en) Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt
AU6255001A (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
SI1265893T1 (sl) Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona